Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...
GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollment Company to seek FDA alignment on global Phase 3 program replicating Phase 2b design Phase 3 initiation targeted ...
The Food and Drug Administration lifted the clinical hold on GH Research's investigational new drug application for its GH001 drug for treatment-resistant depression. The company said the lift allows ...
FDA Commissioner Dr. Marty Makary discusses the new US dietary guidelines that call for more protein and less processed food. Speaking on "Bloomberg The Close," Dr. Makary also comments on the recent ...
Novavax Inc (NASDAQ:NVAX) shares are trading higher. Reports show a rise in respiratory illnesses across the United States.
Fewer people in Massachusetts are getting their seasonal flu and COVID vaccinations as the number of respiratory infections in the state continues to rise. "Certainly we're going to see more cases of ...
Add Yahoo as a preferred source to see more of our stories on Google. People who get a flu shot are less likely to become severely ill, be hospitalized or die. - Kylie Cooper/Reuters/File Flu is ...
Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, on Tuesday called the seasonal flu vaccine “controversial of late” and advised various Make America Healthy Again (MAHA) ...
Sickness is surging across the United States following the holiday season, bringing thermometers and medicine to homes amid presents and Christmas dinner leftovers. New York state especially has been ...
IT’S NOT TOO LATE. YOU CAN STILL GET BENEFIT FROM IT. BUT FIRST, AT 530, PROTECTING YOUR FAMILY FROM ILLNESS, FLU AND COVID CASES ARE ON THE RISE IN KENTUCKY. ADDIE MEINERS SPOKE WITH THE DOCTOR AT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results